MedTrace Logo

The Effects of Topical Calcium Glycerophosphate on Surgical Wound Healing and Residual Scarring

NCT01264588 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-12-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether topical application of calcium glycerophosphate will result in superior wound appearance and scar minimization.

Conditions

  • Wound Healing
  • Scarring

Interventions

OTHER

Topical calcium glycerophosphate lotion

2g once daily for 6 weeks (post-op day 3 thru 42)

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    collaborator OTHER

  • Texas Tech University Health Sciences Center

    collaborator OTHER

  • Cyberderm Inc.

    collaborator INDUSTRY

  • Bacharach Institute for Rehabilitation, Pomona, NJ

    collaborator OTHER

  • AkPharma Inc.

    lead INDUSTRY

Principal Investigators

  • Alvin C. Ong, M.D. · Rothman Institute Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01264588 on ClinicalTrials.gov